Business

FSD Pharma Announces Analyst Coverage Initiated by Singular Research

TORONTO, ON / ACCESSWIRE / September 13, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A...

articleQuantum Biopharma Ltd. Subordinate Voting Shares Class BSeptember 13, 20233/company/quantum-biopharma-ltd-ordinary-shares-class-b-sub-voting/news/fsd-pharma-announces-analyst-coverage-initiated-by-singular-research
FSD Pharma Announces Analyst Coverage Initiated by Singular Research

About this update from Quantum Biopharma Ltd. Subordinate Voting Shares Class B

[{"type":"text","content":"FSD Pharma Announces Analyst Coverage Initiated by Singular ResearchTORONTO, ON / ACCESSWIRE / September 13, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) (\"FSD Pharma\" or the \"Company\"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders, today announced that Singular Research has initiated analyst coverage on FSD Pharma.A copy of the report can be obtained directly from the analyst at Singular Research by contacting BJ Cook, CFA, on 818-222-6234 or at [email protected] Pharma has not paid for this Research Report prepared by Singular Research. All reports on FSD Pharma prepared by analysts represent the views of such analysts and are not necessarily those of FSD Pharma. FSD Pharma is not responsible for the content, accuracy or timelines provided by analysts.About FSD PharmaFSD Pharma Inc. is a biotechnology company with two candidates in different stages of development. Lucid Psychss Inc., a wholly owned subsidiary, is focused on the research and development of its lead compounds, Lucid-MS and UNBUZZD™. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD™ is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.Forward Looking InformationThis press release contains forward-looking statements and forward-looking information (collectively, \"forward-looking statements\") within the meaning of applicable securities laws. Any statements that are contained in this press release that are not statements of historical fact may be deemed to be forward-looking statements. Forward-looking statements are often identified by terms such as \"plans\", \"expects\", \"expected\", \"scheduled\", \"estimates\", \"intends\", \"anticipates\", \"hopes\", \"planned\" or \"believes\", or variations of such words and phrases, or states that certain actions, events or results \"may\", \"could\", \"would\", \"might\", \"potentially\" or \"will\" be taken, occur or be achieved. More particularly, and without limitation, this pr...

More updates from Quantum Biopharma Ltd. Subordinate Voting Shares Class B